Skip to main content
Caplight Logo









Avertix Medical

Avertix Medical

Private
Eatontown, New JerseyHealthcare & Life Scienceshttps://avertix.com/

Last Round

Series C

Aug 10, 2024

Est. Valuation

$10.87M

Total Funding Raised

$14.59M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Avertix Medical is a medical technology company that develops and commercializes implantable cardiac monitoring devices for the detection of acute coronary syndrome events.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT

Business Model

B2B

Customer Profile

Hardware Sales, Revenue Share

AI Layer

Application

Keywords

implantable cardiac monitorheart attack detectionacute coronary syndromeACScardiac rhythm managementremote patient monitoringRPMmedical devicecardiology techhealth IoTAI medical devicewearable heart monitordigital healthmedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Avertix Medical Comparables

Compare Avertix Medical with similar companies based on industry and business-model similarity.

Avertix Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Medtronic
70%
Cortex, Inc.
69%
BIOTRONIK
67%

Avertix Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CAug 10, 2024
Early FundingNov 13, 2023
M&AOct 5, 2023
Series BFeb 10, 2023
VC RoundMar 13, 2020
VC Round
Dec 17, 2012

Key People

Founding team and executive leadership

Dave Keenan

Chief Executive Officer, Vice President Clinical & Regulatory Affairs

Executive Team

David Fischell

CEO

Executive Team

Philip Tom

Executive Vice President & Chief Financial Officer

Executive Team

Avertix Medical Investors

Notable investors and investment history

Avertix Medical investors
InvestorRounds
Hydrix VenturesVC Round, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors grew 100% MoM, reaching 3.3K.

  • Apr 20, 2026

    Monthly visitors increased 44% MoM.

Avertix Medical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Avertix Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Avertix Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersEatontown, New Jersey
Employee Range34
Year Founded2001
Last FundingAug 10, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?